{"id":93063,"date":"2024-10-29T16:40:02","date_gmt":"2024-10-29T15:40:02","guid":{"rendered":"https:\/\/www.formycon.com\/?page_id=93063"},"modified":"2026-01-13T08:17:43","modified_gmt":"2026-01-13T07:17:43","slug":"directors-dealings","status":"publish","type":"page","link":"https:\/\/www.formycon.com\/en\/investor-relations\/directors-dealings\/","title":{"rendered":"Directors Dealings"},"content":{"rendered":"

[vc_row row_height_percent=”0″ override_padding=”yes” h_padding=”2″ top_padding=”0″ bottom_padding=”0″ overlay_alpha=”50″ gutter_size=”3″ column_width_percent=”100″ shift_y=”0″ z_index=”0″][vc_column column_width_percent=”100″ gutter_size=”3″ override_padding=”yes” column_padding=”3″ back_color=”color-xsdn” overlay_alpha=”50″ shift_x=”0″ shift_y=”-3″ shift_y_fixed=”yes” shift_y_down=”0″ z_index=”0″ medium_width=”0″ mobile_width=”0″ width=”1\/1″][vc_row_inner row_inner_height_percent=”0″ overlay_alpha=”50″ equal_height=”yes” gutter_size=”0″ shift_y=”0″][vc_column_inner column_width_use_pixel=”yes” position_vertical=”middle” align_horizontal=”align_center” gutter_size=”3″ override_padding=”yes” column_padding=”0″ overlay_alpha=”50″ shift_x=”0″ shift_y=”0″ shift_y_down=”0″ z_index=”0″ medium_width=”2″ align_mobile=”align_center_mobile” mobile_width=”0″ width=”1\/1″ column_width_pixel=”800″][vc_custom_heading text_color=”color-155072″ heading_semantic=”h1″ text_size=”h5″ text_weight=”700″ text_transform=”uppercase” text_space=”fontspace-210350″ separator_color=”yes” separator=”yes” uncode_shortcode_id=”121944″ text_color_type=”uncode-palette”]Directors’ Dealings[\/vc_custom_heading][vc_custom_heading text_color=”color-186842″ heading_semantic=”p” text_weight=”700″ uncode_shortcode_id=”204582″ text_color_type=”uncode-palette”]Personal trades by the Management Board
\nand Supervisory Board[\/vc_custom_heading][vc_custom_heading heading_semantic=”p” text_size=”h3″ text_weight=”300″ text_height=”fontheight-357766″ uncode_shortcode_id=”214001″]According to article 19 of Market Abuse Regulation, persons with managerial responsibilities, as well as persons closely related to them, are required to report the purchase and sale of Company shares, or other financial instruments relating thereto, to the German Federal Financial Supervisory Authority (BaFin) and to the Company if the total value of such transactions effected within a calendar year is equal to or more than EUR 5,000.<\/p>\n

Such transactions are, in accordance with German law, promptly published by Formycon upon such notification.[\/vc_custom_heading][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row row_height_percent=”0″ override_padding=”yes” h_padding=”2″ top_padding=”2″ bottom_padding=”5″ overlay_alpha=”50″ gutter_size=”3″ column_width_percent=”100″ shift_y=”0″ z_index=”0″][vc_column column_width_use_pixel=”yes” align_horizontal=”align_center” gutter_size=”3″ overlay_alpha=”50″ shift_x=”0″ shift_y=”0″ shift_y_down=”0″ z_index=”0″ medium_width=”0″ mobile_width=”0″ width=”1\/1″ uncode_shortcode_id=”185567″ column_width_pixel=”1200″][vc_row_inner][vc_column_inner column_width_percent=”100″ align_horizontal=”align_center” gutter_size=”3″ overlay_alpha=”50″ shift_x=”0″ shift_y=”0″ shift_y_down=”0″ z_index=”0″ medium_width=”0″ mobile_width=”0″ width=”1\/1″ uncode_shortcode_id=”192482″][vc_separator sep_color=”color-jevc” uncode_shortcode_id=”125613″ sep_color_type=”uncode-palette” el_width=”60%”][vc_empty_space empty_h=”2″][vc_column_text uncode_shortcode_id=”151275″]<\/p>\n

General information on the following managers transactions announcements
\naccording to article 19 MAR<\/strong><\/p>\n

Description of the financial instrument:\u00a0Share<\/strong><\/p>\n

Name of issuer:\u00a0Formycon<\/strong>\u00a0AG<\/strong><\/p>\n

ISIN of the financial instrument:\u00a0DE000A1EWVY8<\/strong><\/p>\n

Legal Entity Identifier (LEI) Code:\u00a039120005TZ76GQOY8Z19<\/strong><\/p>\n

[\/vc_column_text][vc_empty_space empty_h=”3″][vc_column_text uncode_shortcode_id=”199961″]\n\n\n\n\t\n\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t
Date<\/th>Name<\/th>Position<\/th>Transaction<\/th>Volume<\/th>Price in \u20ac<\/th>Volume in \u20ac<\/th>Publication<\/th>\n<\/tr>\n<\/thead>\n
02\/21\/2025<\/td>Dr. Andreas Seidl<\/td>Executive Board Member (CSO)<\/td>Purchase<\/td>160<\/td>30<\/td>4,800.00<\/td>Download<\/u><\/a><\/td>\n<\/tr>\n
04\/25\/2024<\/td>Nicola Mikulcik<\/td>Executive Board Member (CBO)<\/td>Purchase<\/td>1,200<\/td>40<\/td>48,000.00<\/td>Download<\/u><\/a><\/td>\n<\/tr>\n
04\/22\/2024<\/td>Dr. Stefan Glombitza<\/td>Executive Board Member (CEO)<\/td>Purchase<\/td>2,340<\/td>39<\/td>91,260.00<\/td>Download<\/u><\/a><\/td>\n<\/tr>\n
04\/22\/2024<\/td>Dr. Stefan Glombitza<\/td>Executive Board Member (CEO)<\/td>Purchase<\/td>160<\/td>38.65<\/td>6,184.00<\/td>Download<\/u><\/a><\/td>\n<\/tr>\n
08\/30\/2022<\/td>Dr. Stefan Glombitza<\/td>Executive Board Member (CEO)<\/td>Sale<\/td>15,000<\/td>76.48<\/td>1,147,200.00<\/td>Download<\/u><\/a><\/td>\n<\/tr>\n
08\/04\/2022<\/td>Dr. Stefan Glombitza<\/td>Executive Board Member (CEO)<\/td>Purchase<\/td>20,000<\/td>19.46<\/td>389,200.00<\/td>Download<\/u><\/a><\/td>\n<\/tr>\n
03\/03\/2021<\/td>Dr. Stefan Glombitza<\/td>Executive Board Member (COO)<\/td>Sale<\/td>15,000<\/td>64.9<\/td>973,500.00<\/td>Download<\/u><\/a><\/td>\n<\/tr>\n
03\/03\/2021<\/td>Dr. Carsten Brockmeyer<\/td>Executive Board Member (CEO)<\/td>Sale<\/td>7,500<\/td>64.9<\/td>486,750.00<\/td>Download<\/u><\/a><\/td>\n<\/tr>\n
03\/03\/2021<\/td>Dr. Nicolas Comb\u00e9<\/td>Executive Board Member (CFO)<\/td>Sale<\/td>15,000<\/td>64.9<\/td>973,500.00<\/td>Download<\/u><\/a><\/td>\n<\/tr>\n
02\/03\/2021<\/td>Dr. Stefan Glombitza<\/td>Executive Board Member (COO)<\/td>Purchase<\/td>15,000<\/td>19.46<\/td>291,900.00<\/td>Download<\/u><\/a><\/td>\n<\/tr>\n
02\/03\/2021<\/td>Dr. Carsten Brockmeyer<\/td>Executive Board Member (CEO)<\/td>Purchase<\/td>7,500<\/td>20.7<\/td>155,250.00<\/td>Download<\/u><\/a><\/td>\n<\/tr>\n
02\/03\/2021<\/td>Dr. Nicolas Comb\u00e9<\/td>Executive Board Member (CFO)<\/td>Purchase<\/td>15,000<\/td>20.7<\/td>310,500.00<\/td>Download<\/u><\/a><\/td>\n<\/tr>\n
11\/14\/2019<\/td>Peter Wendeln (Wendeln & Cie. KG)<\/td>Member of the Supervisory Board<\/td>Sale<\/td>72,000<\/td>30.9<\/td>2,224,800.00<\/td>Download<\/u><\/a><\/td>\n<\/tr>\n
07\/23\/2019<\/td>Dr. Nicolas Comb\u00e9<\/td>Executive Board Member (CFO)<\/td>Others<\/td>25,000<\/td>5.52<\/td>138,000.00<\/td>Download<\/u><\/a><\/td>\n<\/tr>\n
07\/23\/2019<\/td>Dr. Carsten Brockmeyer<\/td>Executive Board Member (CEO)<\/td>Others<\/td>25,000<\/td>5.52<\/td>138,000.00<\/td>Download<\/u><\/a><\/td>\n<\/tr>\n
06\/26\/2019<\/td>Peter Wendeln (Wendeln & Cie. KG)<\/td>Member of the Supervisory Board<\/td>Purchase<\/td>577,397<\/td>29.9<\/td>17,264,170.30<\/td>Download<\/u><\/a><\/td>\n<\/tr>\n
06\/05\/2019<\/td>Peter Wendeln (Wendeln & Cie. KG)<\/td>Member of the Supervisory Board<\/td>Others<\/td>Not Quantifiable<\/td>Not Quantifiable<\/td>Not Quantifiable<\/td>Download<\/u><\/a><\/td>\n<\/tr>\n
08\/10\/2018<\/td>Dr. Nicolas Comb\u00e9<\/td>Executive Board Member (CFO)<\/td>Sale<\/td>25,000<\/td>33.48<\/td>837,000.00<\/td>Download<\/u><\/a><\/td>\n<\/tr>\n
08\/10\/2018<\/td>Dr. Carsten Brockmeyer<\/td>Executive Board Member (CEO)<\/td>Sale<\/td>25,000<\/td>33.48<\/td>837,000.00<\/td>Download<\/u><\/a><\/td>\n<\/tr>\n
07\/21\/2018<\/td>Dr. Nicolas Comb\u00e9<\/td>Executive Board Member (CFO)<\/td>Purchase<\/td>25,000<\/td>7.59<\/td>189,750.00<\/td>Download<\/u><\/a><\/td>\n<\/tr>\n
07\/21\/2018<\/td>Dr. Carsten Brockmeyer<\/td>Executive Board Member (CEO)<\/td>Purchase<\/td>25,000<\/td>7.59<\/td>189,750.00<\/td>Download<\/u><\/a><\/td>\n<\/tr>\n
09\/05\/2017<\/td>Dr. Nicolas Comb\u00e9<\/td>Executive Board Member (CFO)<\/td>Sale<\/td>15,000<\/td>31.6<\/td>474,000.00<\/td>Download<\/u><\/a><\/td>\n<\/tr>\n
09\/05\/2017<\/td>Dr. Carsten Brockmeyer<\/td>Executive Board Member (CEO)<\/td>Sale<\/td>15,000<\/td>31.6<\/td>474,000.00<\/td>Download<\/u><\/a><\/td>\n<\/tr>\n
07\/14\/2017<\/td>Dr. Nicolas Comb\u00e9<\/td>Executive Board Member (CFO)<\/td>Purchase<\/td>15,000<\/td>4.33<\/td>64,950.00<\/td>Download<\/u><\/a><\/td>\n<\/tr>\n
07\/14\/2017<\/td>Dr. Carsten Brockmeyer<\/td>Executive Board Member (CEO)<\/td>Purchase<\/td>15,000<\/td>4.33<\/td>64,950.00<\/td>Download<\/u><\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner column_width_percent=”100″ align_horizontal=”align_center” gutter_size=”3″ overlay_alpha=”50″ shift_x=”0″ shift_y=”0″ shift_y_down=”0″ z_index=”0″ medium_width=”0″ mobile_width=”0″ width=”1\/1″ uncode_shortcode_id=”192482″][vc_separator sep_color=”color-jevc” uncode_shortcode_id=”125613″ sep_color_type=”uncode-palette” el_width=”60%”][vc_empty_space empty_h=”2″][vc_column_text uncode_shortcode_id=”180278″]<\/p>\n

General information on the following managers transactions announcements
\naccording to article 19 MAR<\/strong><\/p>\n

Description of the financial instrument:\u00a0Bond<\/strong><\/p>\n

Name of issuer:\u00a0Formycon<\/strong>\u00a0AG<\/strong><\/p>\n

ISIN of the financial instrument: NO0013586024<\/strong><\/p>\n

Legal Entity Identifier (LEI) Code: 39120005TZ76GQOY8Z19<\/strong><\/p>\n

[\/vc_column_text][vc_empty_space empty_h=”3″][vc_column_text uncode_shortcode_id=”667444″]\n\n\n\n\t\n\n\t\n\t\n\t
Date<\/th>Name<\/th>Position<\/th>Transaction<\/th>Volume<\/th>Price in %<\/th>Volume in \u20ac<\/th>Publication<\/th>\n<\/tr>\n<\/thead>\n
01\/12\/2026<\/td>Klaus R\u00f6hrig<\/td>Member of the Supervisory Board<\/td>Sale<\/td>100,000<\/td>96.50<\/td>96,500.00<\/td>Download<\/u><\/a><\/td>\n<\/tr>\n
01\/07\/2026<\/td>Klaus R\u00f6hrig<\/td>Member of the Supervisory Board<\/td>Sale<\/td>100,000<\/td>96.25<\/td>96,250.00<\/td>Download<\/u><\/a><\/td>\n<\/tr>\n
01\/06\/2026<\/td>Klaus R\u00f6hrig<\/td>Member of the Supervisory Board<\/td>Sale<\/td>700,000<\/td>95.00<\/td>665,000.00<\/td>Download<\/u><\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

[vc_row row_height_percent=”0″ override_padding=”yes” h_padding=”2″ top_padding=”0″ bottom_padding=”0″ overlay_alpha=”50″ gutter_size=”3″ column_width_percent=”100″ shift_y=”0″ z_index=”0″][vc_column column_width_percent=”100″ gutter_size=”3″ override_padding=”yes” column_padding=”3″ back_color=”color-xsdn” overlay_alpha=”50″ shift_x=”0″ shift_y=”-3″ shift_y_fixed=”yes” […]<\/p>\n","protected":false},"author":23,"featured_media":94030,"parent":78112,"menu_order":11,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":"","_links_to":"","_links_to_target":""},"class_list":["post-93063","page","type-page","status-publish","has-post-thumbnail","hentry","page_category-ir-update-en"],"acf":[],"yoast_head":"\nDirectors Dealings - Formycon AG<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.formycon.com\/en\/investor-relations\/directors-dealings\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Directors Dealings - Formycon AG\" \/>\n<meta property=\"og:description\" content=\"[vc_row row_height_percent=”0″ override_padding=”yes” h_padding=”2″ top_padding=”0″ bottom_padding=”0″ overlay_alpha=”50″ gutter_size=”3″ column_width_percent=”100″ shift_y=”0″ z_index=”0″][vc_column column_width_percent=”100″ gutter_size=”3″ override_padding=”yes” column_padding=”3″ back_color=”color-xsdn” overlay_alpha=”50″ shift_x=”0″ shift_y=”-3″ shift_y_fixed=”yes” […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.formycon.com\/en\/investor-relations\/directors-dealings\/\" \/>\n<meta property=\"og:site_name\" content=\"Formycon AG\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-13T07:17:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.formycon.com\/wp-content\/uploads\/2024\/11\/DD215703713.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1600\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.formycon.com\/en\/investor-relations\/directors-dealings\/\",\"url\":\"https:\/\/www.formycon.com\/en\/investor-relations\/directors-dealings\/\",\"name\":\"Directors Dealings - Formycon AG\",\"isPartOf\":{\"@id\":\"https:\/\/www.formycon.com\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.formycon.com\/en\/investor-relations\/directors-dealings\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.formycon.com\/en\/investor-relations\/directors-dealings\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.formycon.com\/wp-content\/uploads\/2024\/11\/DD215703713.jpg\",\"datePublished\":\"2024-10-29T15:40:02+00:00\",\"dateModified\":\"2026-01-13T07:17:43+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.formycon.com\/en\/investor-relations\/directors-dealings\/#breadcrumb\"},\"inLanguage\":\"en\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.formycon.com\/en\/investor-relations\/directors-dealings\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en\",\"@id\":\"https:\/\/www.formycon.com\/en\/investor-relations\/directors-dealings\/#primaryimage\",\"url\":\"https:\/\/www.formycon.com\/wp-content\/uploads\/2024\/11\/DD215703713.jpg\",\"contentUrl\":\"https:\/\/www.formycon.com\/wp-content\/uploads\/2024\/11\/DD215703713.jpg\",\"width\":1600,\"height\":600,\"caption\":\"Smiling pretty young business lady in jacket talking to colleague and discussing business forum topics during break\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.formycon.com\/en\/investor-relations\/directors-dealings\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.formycon.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Investors\",\"item\":\"https:\/\/www.formycon.com\/en\/investor-relations\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Directors Dealings\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.formycon.com\/en\/#website\",\"url\":\"https:\/\/www.formycon.com\/en\/\",\"name\":\"Formycon AG\",\"description\":\"Global Quality Biosimilars\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.formycon.com\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Directors Dealings - Formycon AG","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.formycon.com\/en\/investor-relations\/directors-dealings\/","og_locale":"en_US","og_type":"article","og_title":"Directors Dealings - Formycon AG","og_description":"[vc_row row_height_percent=”0″ override_padding=”yes” h_padding=”2″ top_padding=”0″ bottom_padding=”0″ overlay_alpha=”50″ gutter_size=”3″ column_width_percent=”100″ shift_y=”0″ z_index=”0″][vc_column column_width_percent=”100″ gutter_size=”3″ override_padding=”yes” column_padding=”3″ back_color=”color-xsdn” overlay_alpha=”50″ shift_x=”0″ shift_y=”-3″ shift_y_fixed=”yes” […]","og_url":"https:\/\/www.formycon.com\/en\/investor-relations\/directors-dealings\/","og_site_name":"Formycon AG","article_modified_time":"2026-01-13T07:17:43+00:00","og_image":[{"width":1600,"height":600,"url":"https:\/\/www.formycon.com\/wp-content\/uploads\/2024\/11\/DD215703713.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.formycon.com\/en\/investor-relations\/directors-dealings\/","url":"https:\/\/www.formycon.com\/en\/investor-relations\/directors-dealings\/","name":"Directors Dealings - Formycon AG","isPartOf":{"@id":"https:\/\/www.formycon.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.formycon.com\/en\/investor-relations\/directors-dealings\/#primaryimage"},"image":{"@id":"https:\/\/www.formycon.com\/en\/investor-relations\/directors-dealings\/#primaryimage"},"thumbnailUrl":"https:\/\/www.formycon.com\/wp-content\/uploads\/2024\/11\/DD215703713.jpg","datePublished":"2024-10-29T15:40:02+00:00","dateModified":"2026-01-13T07:17:43+00:00","breadcrumb":{"@id":"https:\/\/www.formycon.com\/en\/investor-relations\/directors-dealings\/#breadcrumb"},"inLanguage":"en","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.formycon.com\/en\/investor-relations\/directors-dealings\/"]}]},{"@type":"ImageObject","inLanguage":"en","@id":"https:\/\/www.formycon.com\/en\/investor-relations\/directors-dealings\/#primaryimage","url":"https:\/\/www.formycon.com\/wp-content\/uploads\/2024\/11\/DD215703713.jpg","contentUrl":"https:\/\/www.formycon.com\/wp-content\/uploads\/2024\/11\/DD215703713.jpg","width":1600,"height":600,"caption":"Smiling pretty young business lady in jacket talking to colleague and discussing business forum topics during break"},{"@type":"BreadcrumbList","@id":"https:\/\/www.formycon.com\/en\/investor-relations\/directors-dealings\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.formycon.com\/en\/"},{"@type":"ListItem","position":2,"name":"Investors","item":"https:\/\/www.formycon.com\/en\/investor-relations\/"},{"@type":"ListItem","position":3,"name":"Directors Dealings"}]},{"@type":"WebSite","@id":"https:\/\/www.formycon.com\/en\/#website","url":"https:\/\/www.formycon.com\/en\/","name":"Formycon AG","description":"Global Quality Biosimilars","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.formycon.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en"}]}},"publishpress_future_action":{"enabled":false,"date":"2026-05-03 10:54:33","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"translation_priority","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/www.formycon.com\/en\/wp-json\/wp\/v2\/pages\/93063","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.formycon.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.formycon.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.formycon.com\/en\/wp-json\/wp\/v2\/users\/23"}],"replies":[{"embeddable":true,"href":"https:\/\/www.formycon.com\/en\/wp-json\/wp\/v2\/comments?post=93063"}],"version-history":[{"count":11,"href":"https:\/\/www.formycon.com\/en\/wp-json\/wp\/v2\/pages\/93063\/revisions"}],"predecessor-version":[{"id":99122,"href":"https:\/\/www.formycon.com\/en\/wp-json\/wp\/v2\/pages\/93063\/revisions\/99122"}],"up":[{"embeddable":true,"href":"https:\/\/www.formycon.com\/en\/wp-json\/wp\/v2\/pages\/78112"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.formycon.com\/en\/wp-json\/wp\/v2\/media\/94030"}],"wp:attachment":[{"href":"https:\/\/www.formycon.com\/en\/wp-json\/wp\/v2\/media?parent=93063"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}